lncRNA requirements for mouse acute myeloid leukemia and normal differentiation

  1. M Joaquina Delás
  2. Leah R Sabin
  3. Egor Dolzhenko
  4. Simon RV Knott
  5. Ester Munera Maravilla
  6. Benjamin T Jackson
  7. Sophia A Wild
  8. Tatjana Kovacevic
  9. Eva Maria Stork
  10. Meng Zhou
  11. Nicolas Erard
  12. Emily Lee
  13. David R Kelley
  14. Mareike Roth
  15. Inês AM Barbosa
  16. Johannes Zuber
  17. John L Rinn
  18. Andrew D Smith  Is a corresponding author
  19. Gregory J Hannon  Is a corresponding author
  1. Cold Spring Harbor Laboratory, United States
  2. University of Southern California, United States
  3. University of Cambridge, United Kingdom
  4. Watson School of Biological Sciences, United States
  5. Harvard University, United States
  6. Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Austria
  7. Cold Spring Harbor Laboratory, United Kingdom

Abstract

A substantial fraction of the genome is transcribed in a cell type-specific manner, producing long non-coding RNAs (lncRNAs), rather than protein-coding transcripts. Here we systematically characterize transcriptional dynamics during hematopoiesis and in hematological malignancies. Our analysis of annotated and de novo assembled lncRNAs showed many are regulated during differentiation and mis-regulated in disease. We assessed lncRNA function via an in vivo RNAi screen in a model of acute myeloid leukemia. This identified several lncRNAs essential for leukemia maintenance, and found that a number act by promoting leukemia stem cell signatures. Leukemia blasts show a myeloid differentiation phenotype when these lncRNAs were depleted, and our data indicates that this effect is mediated via effects on the c-MYC oncogene. Bone marrow reconstitutions showed that a lncRNA expressed across all progenitors was required for the myeloid lineage, whereas the other leukemia-induced lncRNAs were dispensable in the normal setting.

Data availability

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. M Joaquina Delás

    Watson School of Biological Sciences, Cold Spring Harbor Laboratory, Cold Spring Harbor, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9727-9068
  2. Leah R Sabin

    Watson School of Biological Sciences, Cold Spring Harbor Laboratory, Cold Spring Harbor, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Egor Dolzhenko

    Molecular and Computational Biology, University of Southern California, Los Angeles, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Simon RV Knott

    Watson School of Biological Sciences, Cold Spring Harbor Laboratory, Cold Spring Harbor, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Ester Munera Maravilla

    Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Benjamin T Jackson

    Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Sophia A Wild

    Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Tatjana Kovacevic

    Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. Eva Maria Stork

    Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Meng Zhou

    Molecular and Computational Biology, University of Southern California, Los Angeles, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Nicolas Erard

    Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  12. Emily Lee

    Cold Spring Harbor Laboratory, Watson School of Biological Sciences, Cold Spring Harbor, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. David R Kelley

    Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Mareike Roth

    Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  15. Inês AM Barbosa

    Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  16. Johannes Zuber

    Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8810-6835
  17. John L Rinn

    Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  18. Andrew D Smith

    Molecular and Computational Biology, University of Southern California, Los Angeles, United States
    For correspondence
    andrewds@usc.edu
    Competing interests
    The authors declare that no competing interests exist.
  19. Gregory J Hannon

    Watson School of Biological Sciences, Cold Spring Harbor Laboratory, Cold Spring Harbor, United Kingdom
    For correspondence
    greg.hannon@cruk.cam.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4021-3898

Funding

Cancer Research UK

  • Gregory J Hannon

Boehringer Ingelheim Fonds (PhD Fellowship)

  • M Joaquina Delás

Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona " (Graduate Studies Fellowship)

  • M Joaquina Delás

National Institutes of Health (R01 HG007650)

  • Andrew D Smith

Damon Runyon Cancer Research Foundation (DRG-2016-12)

  • Leah R Sabin

Howard Hughes Medical Institute (Investigator)

  • Gregory J Hannon

Wellcome Trust (Investigator)

  • Gregory J Hannon

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: For animal experiments conducted at Cold Spring Harbor Laboratory, all the animals were handled according to the approved institutional animal care and use committee (IACUC) protocol (#14-11-18). For animal experiments conducted at CRUK Cambridge Institute, all the animals were handled according to project and personal licenses issued under the United Kingdom Animals (Scientific Procedures) Act, 1986 (PPL 70/8391).

Copyright

© 2017, Delás et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,275
    views
  • 698
    downloads
  • 57
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. M Joaquina Delás
  2. Leah R Sabin
  3. Egor Dolzhenko
  4. Simon RV Knott
  5. Ester Munera Maravilla
  6. Benjamin T Jackson
  7. Sophia A Wild
  8. Tatjana Kovacevic
  9. Eva Maria Stork
  10. Meng Zhou
  11. Nicolas Erard
  12. Emily Lee
  13. David R Kelley
  14. Mareike Roth
  15. Inês AM Barbosa
  16. Johannes Zuber
  17. John L Rinn
  18. Andrew D Smith
  19. Gregory J Hannon
(2017)
lncRNA requirements for mouse acute myeloid leukemia and normal differentiation
eLife 6:e25607.
https://doi.org/10.7554/eLife.25607

Share this article

https://doi.org/10.7554/eLife.25607

Further reading

    1. Developmental Biology
    Natsuko Emura, Florence DM Wavreil ... Mamiko Yajima
    Research Article

    The evolutionary introduction of asymmetric cell division (ACD) into the developmental program facilitates the formation of a new cell type, contributing to developmental diversity and, eventually, species diversification. The micromere of the sea urchin embryo may serve as one of those examples: an ACD at the 16-cell stage forms micromeres unique to echinoids among echinoderms. We previously reported that a polarity factor, activator of G-protein signaling (AGS), plays a crucial role in micromere formation. However, AGS and its associated ACD factors are present in all echinoderms and across most metazoans. This raises the question of what evolutionary modifications of AGS protein or its surrounding molecular environment contributed to the evolutionary acquisition of micromeres only in echinoids. In this study, we learned that the GoLoco motifs at the AGS C-terminus play critical roles in regulating micromere formation in sea urchin embryos. Further, other echinoderms’ AGS or chimeric AGS that contain the C-terminus of AGS orthologs from various organisms showed varied localization and function in micromere formation. In contrast, the sea star or the pencil urchin orthologs of other ACD factors were consistently localized at the vegetal cortex in the sea urchin embryo, suggesting that AGS may be a unique variable factor that facilitates ACD diversity among echinoderms. Consistently, sea urchin AGS appears to facilitate micromere-like cell formation and accelerate the enrichment timing of the germline factor Vasa during early embryogenesis of the pencil urchin, an ancestral type of sea urchin. Based on these observations, we propose that the molecular evolution of a single polarity factor facilitates ACD diversity while preserving the core ACD machinery among echinoderms and beyond during evolution.

    1. Developmental Biology
    Pénélope Tignard, Karen Pottin ... Marie Anne Breau
    Research Article

    Despite recent progress, the complex roles played by the extracellular matrix in development and disease are still far from being fully understood. Here, we took advantage of the zebrafish sly mutation which affects Laminin γ1, a major component of basement membranes, to explore its role in the development of the olfactory system. Following a detailed characterisation of Laminin distribution in the developing olfactory circuit, we analysed basement membrane integrity, olfactory placode and brain morphogenesis, and olfactory axon development in sly mutants, using a combination of immunochemistry, electron microscopy and quantitative live imaging of cell movements and axon behaviours. Our results point to an original and dual contribution of Laminin γ1-dependent basement membranes in organising the border between the olfactory placode and the adjacent brain: they maintain placode shape and position in the face of major brain morphogenetic movements, they establish a robust physical barrier between the two tissues while at the same time allowing the local entry of the sensory axons into the brain and their navigation towards the olfactory bulb. This work thus identifies key roles of Laminin γ1-dependent basement membranes in neuronal tissue morphogenesis and axon development in vivo.